Lista de

Vasoactive Intestinal Peptide
27
"VIP induces the decidualization program and conditions the immunoregulation of the implantation process" (2018) Grasso, E.;Gori, S.;Paparini, D. (...)Ramhorst, R. Molecular and Cellular Endocrinology. 460:63-72
"Progesterone and VIP cross-talk enhances phagocytosis and anti-inflammatory profile in trophoblast-derived cells" (2017) Vota, D.;Aguero, M.;Grasso, E. (...)Ramhorst, R. Molecular and Cellular Endocrinology. 443:146-154
"VIP boosts regulatory T cell induction by trophoblast cells in an in vitro model of trophoblast–maternal leukocyte interaction" (2015) Fraccaroli, L.;Grasso, E.;Hauk, V. (...)Ramhorst, R. Journal of Leukocyte Biology. 98(1):49-58
"VIP contribution to the decidualization program: Regulatory T cell recruitment" (2014) Grasso, E.;Paparini, D.;Agüero, M. (...)Ramhorst, R. Journal of Endocrinology. 221(1):121-131
"Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis" (2014) Hauk, V.;Fraccaroli, L.;Grasso, E. (...)Pérez Leirós, C. Clinical and Experimental Immunology. 177(3):662-670
"Tolerance Induction at the Early Maternal-Placental Interface Through Selective Cell Recruitment and Targeting by Immune Polypeptides" (2013) Pérez Leirós, C.; Ramhorst, R. American Journal of Reproductive Immunology. 69(4):359-368
"Tolerance Induction at the Early Maternal-Placental Interface Through Selective Cell Recruitment and Targeting by Immune Polypeptides" (2013) Pérez Leirós, C.; Ramhorst, R. American Journal of Reproductive Immunology. 69(4):359-368
"Modulation of Maternal LIF Producers T Cells by Trophoblast and Paternal Antigens" (2011) Fraccaroli, L.;Grasso, E.;Zeitler, E. (...)Ramhorst, R. American Journal of Reproductive Immunology. 65(2):133-145
"Vasoactive intestinal peptide inhibits TNF-α-induced apoptotic events in acinar cells from nonobese diabetic mice submandibular glands" (2009) Calafat, M.;Larocca, L.;Roca, V. (...)Pérez Leirós, C. Arthritis Research and Therapy. 11(2)
"Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice" (2009) Roca, V.;Calafat, M.;Larocca, L. (...)Pérez Leirós, C. Reproduction. 138(4):733-742
"VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells" (2009) Fraccaroli, L.;Alfieri, J.;Larocca, L. (...)Leirós, C.P. British Journal of Pharmacology. 156(1):116-126
"VIP limits LPS-induced nitric oxide production through IL-10 in NOD mice macrophages" (2007) Larocca, L.;Calafat, M.;Roca, V. (...)Leirós, C.P. International Immunopharmacology. 7(10):1343-1349
"NOD mice exocrinopathy: Towards a neuroimmune link" (2007) Calafat, M.; Larocca, L.; Roca, V.; Pérez Leirós, C. NeuroImmunoModulation. 14(3-4):175-181
"Reduced nitric oxide synthase and cyclo-oxygenase activity in the uterus of non-obese diabetic mice" (2006) Roca, V.;Larocca, L.;Calafat, M. (...)Leirós, C.P. Reproduction. 132(6):931-938
"Defective signalling in salivary glands precedes the autoimmune response in the non-obese diabetic mouse model of sialadenitis" (2005) Rosignoli, F.;Roca, V.;Meiss, R. (...)Leirós, C.P. Clinical and Experimental Immunology. 142(3):411-418
"Nitric oxide synthase I and VIP-activated signaling are affected in salivary glands of NOD mice" (2002) Rosignoli, F.; Pérez Leirós, C. Journal of Neuroimmunology. 130(1-2):109-116